Risk-Benefit Analysis Of Covid-19 Vaccine In Children Aged 5 To 11 — Dr Musa Mohd Nordin, Dr Hung Liang Choo, Dr Amar-Singh HSS & Dr Zulkifli Ismail – CodeBlue – CodeBlue

This article is a follow-up to our earlier article on the vaccination of children 5 to 11 with the Pfizer vaccine.
Since we do not have risk benefit analysis for Covid-19 vaccination in children 5 to 11, it is best to refer to a study by the United States’…

Click here to view the original article.